🇺🇸 FDA

Intelligence Platform

Patents

Browse 71 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 7531623

Hydrochloride salts of a glycopeptide phosphonate derivative

Theravance, Inc. · Granted Tue May 12 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 07 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7507861

Process for the preparation of atomoxetine hydrochloride

Teva Pharmaceutical Fine Chemicals S.R.L. · Granted Tue Mar 24 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7488758

Levalbuterol hydrochloride polymorph B

Teva Pharmaceutical Fine Chemicals S.R.L. · Granted Tue Feb 10 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 05 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7465831

Levalbuterol hydrochloride Polymorph A

Teva Pharmaceutical Fine Chemicals S.R.L. · Granted Tue Dec 16 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 11 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7462743

Polymorphs of memantine hydrochloride

Teva Pharmaceutical Fine Chemicals S.R.L. · Granted Tue Dec 09 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 04 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7439399

Processes for the preparation of atomoxetine hydrochloride

Teva Pharmaceutical Fine Chemicals S.R.L. · Granted Tue Oct 21 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 16 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7396542

Stable pharmaceutical formulation of paroxetine hydrochloride anhydrous and a process for

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Jul 08 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 03 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7368606

Amorphous cinacalcet hydrochloride and preparation thereof

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue May 06 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 01 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7357945

Stable pharmaceutical formulation of paroxetine hydrochloride and a process for preparatio

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Apr 15 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 10 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7319171

Sertraline hydrochloride form II and methods for the preparation thereof

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Jan 15 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 10 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7247751

Processes for preparing cinacalcet hydrochloride crystal Form I

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Jul 24 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 19 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7196222

Sertraline hydrochloride form II and methods for the preparation thereof

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Mar 27 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 22 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7138137

Stable pharmaceutical formulation of paroxetine hydrochloride and a process for preparatio

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Nov 21 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 16 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7022881

Sertraline hydrochloride polymorphs

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Apr 04 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 30 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6936720

Method for preparing benzisoxazole methane sulfonyl chloride and its amidation to form zon

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Aug 30 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 25 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6858652

Sertraline hydrochloride polymorphs, processes for preparing them, compositions containing

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Feb 22 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 17 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6849736

Crystalline forms of valacyclovir hydrochloride

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Feb 01 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 27 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6600073

Methods for preparation of sertraline hydrochloride polymorphs

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Jul 29 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 24 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6500987

Sertraline hydrochloride polymorphs

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Dec 31 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 26 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6495721

Sertraline hydrochloride Form II and methods for the preparation thereof

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Dec 17 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 12 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6452054

Sertraline hydrochloride polymorphs, processes for preparing them, compositions containing

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Sep 17 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 12 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6306436

Stabilized, acid-free formulation for sustained release of bupropion hydrochloride

Teva Pharmaceuticals USA, Inc. · Granted Tue Oct 23 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 18 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6248888

Process for the preparation of terazosin hydrochloride dihydrate

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Jun 19 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 14 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired